Literature DB >> 22446566

Toxoplasma gondii and other risk factors for schizophrenia: an update.

E Fuller Torrey1, John J Bartko, Robert H Yolken.   

Abstract

The failure to find genes of major effect in schizophrenia has refocused attention on nongenetic, including infectious factors. In a previous study, antibodies to Toxoplasma gondii were found to be elevated in 23 studies of schizophrenia (OR 2.73; 95% CI 2.10-3.60). The current study replicates this finding with 15 additional studies (OR 2.71; 95% CI 1.93-3.80) and compares this with other identified schizophrenia risk factors. The highest risk factors are having an affected mother (relative risks [RR] 9.31; 95% CI 7.24-11.96), father (RR 7.20; 95% CI 5.10-10.16), or sibling (RR 6.99; 95% CI 5.38-9.08) or being the offspring of immigrants from selected countries (RR 4.5; 95% CI 1.5-13.1). Intermediate risk factors, in addition to infection with T. gondii, include being an immigrant from and to selected countries (RR 2.7; 95% CI 2.3-3.2), being born in (RR 2.24; 95% CI 1.92-2.61) or raised in (RR 2.75; 95% CI 2.31-3.28) an urban area, cannabis use (OR 2.10-2.93; 95% CI 1.08-6.13), having minor physical anomalies (OR 2.23; 95% CI 1.42-3.58), or having a father 55 or older (OR 2.21-5.92; 95% CI 1.46-17.02). Low-risk factors include a history of traumatic brain injury (OR 1.65; 95% CI 1.17-2.32), sex abuse in childhood (OR 1.46; 95% CI 0.84-2.52), obstetrical complications (OR 1.29-1.38; 95% CI 1.00-1.84), having a father 45 or older (OR 1.21-1.66; 95% CI 1.09-2.01), specific genetic polymorphisms (OR 1.09-1.24; 95% CI 1.06-1.45), birth seasonality (OR 1.07-1.95; 95% CI 1.05-2.91), maternal exposure to influenza (RR 1.05; 95% CI 0.98-1.12), or prenatal stress (RR 0.98-1.00; 95% CI 0.85-1.16).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22446566      PMCID: PMC3329973          DOI: 10.1093/schbul/sbs043

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  38 in total

Review 1.  Are some cases of psychosis caused by microbial agents? A review of the evidence.

Authors:  R H Yolken; E F Torrey
Journal:  Mol Psychiatry       Date:  2008-02-12       Impact factor: 15.992

2.  Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies.

Authors:  Charlene Molloy; Ronan M Conroy; David R Cotter; Mary Cannon
Journal:  Schizophr Bull       Date:  2011-08-02       Impact factor: 9.306

3.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.

Authors:  Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

4.  Paternal age as a risk factor for schizophrenia: how important is it?

Authors:  E Fuller Torrey; Stephen Buka; Tyrone D Cannon; Jill M Goldstein; Larry J Seidman; Tianli Liu; Trevor Hadley; Isabelle M Rosso; Carrie Bearden; Robert H Yolken
Journal:  Schizophr Res       Date:  2009-08-14       Impact factor: 4.939

5.  Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk.

Authors:  C B Pedersen; P B Mortensen
Journal:  Arch Gen Psychiatry       Date:  2001-11

6.  Seropositivity of toxoplasmosis in patients with schizophrenia.

Authors:  Amel A El-Sahn; Hanan Z Shatat; Engy M Ghitany
Journal:  J Egypt Public Health Assoc       Date:  2005

7.  A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.

Authors:  Dunja Hinze-Selch; Walter Däubener; Lena Eggert; Sükran Erdag; Renate Stoltenberg; Sibylle Wilms
Journal:  Schizophr Bull       Date:  2007-03-26       Impact factor: 9.306

8.  Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.

Authors:  Yared Tedla; Teshome Shibre; Oumer Ali; Geletta Tadele; Yimtubezinash Woldeamanuel; Daniel Asrat; Abraham Aseffa; Wude Mihret; Markos Abebe; Atalaye Alem; Girmay Medhin; Abebe Habte
Journal:  Ethiop Med J       Date:  2011-07

Review 9.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

10.  Genetic associations with schizophrenia: meta-analyses of 12 candidate genes.

Authors:  Jiajun Shi; Elliot S Gershon; Chunyu Liu
Journal:  Schizophr Res       Date:  2008-08-20       Impact factor: 4.939

View more
  131 in total

Review 1.  Induced pluripotent stem cells for modeling neurological disorders.

Authors:  Fabiele B Russo; Fernanda R Cugola; Isabella R Fernandes; Graciela C Pignatari; Patricia C B Beltrão-Braga
Journal:  World J Transplant       Date:  2015-12-24

Review 2.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 3.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 4.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

5.  Positive association between Toxoplasma gondii IgG serointensity and current dysphoria/hopelessness scores in the Old Order Amish: a preliminary study.

Authors:  Abhishek Wadhawan; Aline Dagdag; Allyson Duffy; Melanie L Daue; Kathy A Ryan; Lisa A Brenner; John W Stiller; Toni I Pollin; Maureen W Groer; Xuemei Huang; Christopher A Lowry; Braxton D Mitchell; Teodor T Postolache
Journal:  Pteridines       Date:  2017-11-22       Impact factor: 0.581

6.  Seasonality of births in horizontal strabismus: comparison with birth seasonality in schizophrenia and other disease conditions.

Authors:  A B Agarwal; K Cassinelli; L A Johnson; K Matsuda; B Kirkpatrick; W Yang; C S von Bartheld
Journal:  J Dev Orig Health Dis       Date:  2019-03-22       Impact factor: 2.401

7.  AAH2 gene is not required for dopamine-dependent neurochemical and behavioral abnormalities produced by Toxoplasma infection in mouse.

Authors:  Ross McFarland; Zi Teng Wang; Yan Jouroukhin; Ye Li; Olga Mychko; Isabelle Coppens; Jianchun Xiao; Lorraine Jones-Brando; Robert H Yolken; L David Sibley; Mikhail V Pletnikov
Journal:  Behav Brain Res       Date:  2018-03-16       Impact factor: 3.332

8.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

Review 9.  Psychiatric disorders in toxoplasma seropositive patients--the CD8 connection.

Authors:  Rajarshi Bhadra; Dustin A Cobb; Louis M Weiss; Imtiaz A Khan
Journal:  Schizophr Bull       Date:  2013-02-20       Impact factor: 9.306

10.  Predictors of a clinical high risk status among individuals with a family history of psychosis.

Authors:  Jacqueline Stowkowy; Jean Addington
Journal:  Schizophr Res       Date:  2013-04-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.